Daily BriefsMost Read

Most Read: Shin Kong Financial Holding, Ibiden Co Ltd, Korea Zinc, ESR Group , Tianjin Port, Hyundai Motor, Tokyo Metro, Sinopec Engineering Group H, CPMC Holdings and more

In today’s briefing:

  • Shin Kong (2888 TT) Deal – Activism, Proxy Advice, Proxy Fight, Voting Risk, and Discounts
  • Shinko Electric (6967 JP) Takeover – Still Buy Dips, and Ibiden (4062 JP)
  • Impact on Korea Zinc’s Balance Sheet and Debt Ratios Post Massive Debt Raise Proposed by Choi Family
  • ESR Group (1821 HK): Inching Closer to a Binding Proposal
  • 7&I (3382) – Asset Sale News Designed to Get Shareholder Attention to Future Value
  • WisdomTree Emerging Markets High Dividend Index Rebalance: US$2.5bn Round-Trip Trade
  • Weekly Deals Digest (06 Oct) – Tokyo Metro, Rigaku, CR Beverage, K Bank, ASMPT, Samson, T-Gaia
  • WisdomTree Emerging Markets SmallCap Dividend Index Rebalance: US$1bn to Trade
  • Korea Zinc: Breaking Down the Cancel Risk with Specific Legal Provisions for Both Camps
  • CPMC Holdings (906.HK) Privatization Update – Will ORG Withdraw Midway?


Shin Kong (2888 TT) Deal – Activism, Proxy Advice, Proxy Fight, Voting Risk, and Discounts

By Travis Lundy


Shinko Electric (6967 JP) Takeover – Still Buy Dips, and Ibiden (4062 JP)

By Travis Lundy

  • In August, Shinko Electric Industries (6967 JP) announced that the JIC consortium Tender Offer due to be launched by end-August would be delayed. Next update? January 2025.
  • Everyone had expected a delay, but the stock fell. Then tech/AI fell out of bed, Ibiden crashed, China export restrictions noise/pushback caused further upset. But Ibiden and tech are rebounding.
  • At 9% it was a raging buy;post-dip at 7% it was good. Now it’s 6+%. Still wide, still interesting, still stable but year-end path dependency… So I still like Ibiden.

Impact on Korea Zinc’s Balance Sheet and Debt Ratios Post Massive Debt Raise Proposed by Choi Family

By Douglas Kim

  • We discuss the impact on the balance sheet and debt ratios of Korea Zinc’s efforts to conduct a massive debt increase to buyback and cancel shares. 
  • Although the Choi family may consider raising further debt to increase the tender offer price even further, we believe this could pose further balance sheet risk on Korea Zinc. 
  • We provide sensitivity analysis of higher debt on the interest coverage ratios of Korea Zinc. 

ESR Group (1821 HK): Inching Closer to a Binding Proposal

By Arun George

  • ESR Group (1821 HK) provided a positive update on the indicative proposal. The update notes that the consortium has expanded from three to six, representing 39.91% of outstanding shares.
  • The addition of new consortium members is a positive. While the recent market rally is not a dealbreaker, it should give the consortium renewed impetus to launch an acceptable offer.   
  • The downside to a deal break is low as ESR’s valuation is undemanding, which is supported by the potential earnings recovery in a more benign interest rate environment.

7&I (3382) – Asset Sale News Designed to Get Shareholder Attention to Future Value

By Travis Lundy

  • Seven & I Holdings (3382 JP) is currently “in limbo” as the initial Alimentation Couche-Tard (ATD CN) (“ACT”) has been rejected, some news is out, and we await earnings/presentations.
  • The news last week was that 7&i might sell down a stake in Seven Bank Ltd (8410 JP) and could sell its retail/superstore business to PE rather than an IPO.
  • Both selldowns mean the focus on CVS everyone seems to want. That’s good news. And the shares are trading at/below ACT terms which “grossly undervalued” the company. Bullish. 

WisdomTree Emerging Markets High Dividend Index Rebalance: US$2.5bn Round-Trip Trade

By Brian Freitas

  • The WisdomTree Emerging Markets High Dividend Index is a fundamentally weighted index that measures the performance of high dividend yield stocks within emerging markets.
  • The changes at the October rebalance were announced after market close on 4 October with implementation scheduled at the close on 16 October.
  • There are 241 adds and 208 deletes for the index with an estimated round-trip trade of US$2.5bn. There are many stocks with over 2x ADV to trade.

Weekly Deals Digest (06 Oct) – Tokyo Metro, Rigaku, CR Beverage, K Bank, ASMPT, Samson, T-Gaia

By Arun George


WisdomTree Emerging Markets SmallCap Dividend Index Rebalance: US$1bn to Trade

By Brian Freitas

  • The WisdomTree Emerging Markets SmallCap Dividend Index is a fundamentally weighted index that measures the performance of small cap stocks within Emerging Markets.
  • The changes at the October rebalance were announced after market close on 4 October with implementation scheduled at the close on 16 October.
  • There are 8 trading days to implementation and there are a bunch of stocks with over 2x ADV to trade.

Korea Zinc: Breaking Down the Cancel Risk with Specific Legal Provisions for Both Camps

By Sanghyun Park

  • MBK is unlikely to lower the tender price or cancel the offer due to legal constraints and potential regulatory hurdles, along with compensating investors.
  • Just keep in mind that if you want to participate in MBK’s Korea Zinc offer, you’ll need to submit your bid to secure that compensation safety net.
  • We can’t rule out the second injunction request being accepted on the 21st, leaving Choi’s camp in a tough position with tender offer cancellation risks compared to MBK.

CPMC Holdings (906.HK) Privatization Update – Will ORG Withdraw Midway?

By Xinyao (Criss) Wang

  • Acquiring CPMC at low price is in line with Baosteel’s strategic goals and the new assessment indicators of Baowu Group. This explains why Baosteel didn’t choose to raise its Offer 
  • ORG intends to acquire 100% equity of CPMC. This means state-owned capital needs to withdraw completely from CPMC. So, would China Foods/COFCO (both SOEs) agree to be acquired by ORG?
  • If ORG is “forced to” acquire CPMC due to Baosteel’s low Offer Price, will ORG change mind and choose to withdraw midway?Such “potential unwillingness” from ORG makes the deal “tricky”.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars